1H3 — Clearbridge Health Cashflow Statement
0.000.00%
Last trade - 00:00
- SG$6.19m
- SG$12.43m
- SG$11.49m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11.4 | 2.12 | -17.9 | -11.2 | -34.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 4.86 | -2.95 | 13.5 | 10 | 30 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -5.27 | -1.32 | -2.73 | -3.5 | -0.565 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -8.63 | 2.61 | -2.99 | -1.98 | -3.58 |
Capital Expenditures | -1.73 | -1.08 | -0.833 | -0.689 | -0.548 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -13.6 | 0.177 | 2.01 | -0.394 | 3.62 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -15.3 | -0.903 | 1.18 | -1.08 | 3.07 |
Financing Cash Flow Items | -3.44 | -0.871 | -0.528 | 2.65 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 26.3 | -1.02 | 2.46 | -2.56 | -1.88 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.32 | 0.797 | 0.819 | -5.65 | -2.38 |